| 书目名称 | The CAPRISA Clinical Trials: HIV Treatment and Prevention | | 编辑 | Quarraisha Abdool Karim,Salim S. Abdool Karim,Cher | | 视频video | http://file.papertrans.cn/906/905589/905589.mp4 | | 概述 | Unique resource for those looking to establish high impact research centers or units.Provides a historical account of the rationale, protocol development, implementation, and communication of a range | | 图书封面 |  | | 描述 | .Since its inception 14 years ago, CAPRISA has conducted numerous clinical studies that have influenced international TB-HIV treatment guidelines as well as HIV prevention through innovations in the microbicide and vaccine fields. This book provides a historical account of how each of CAPRISA’s high impact studies was created, developed, implemented, analysed and communicated. In doing so, the reader is taken on a journey that provides glimpses into the genesis of research ideas and how this ultimately leads to a range of HIV prevention and treatment studies that have impacted the global response to the HIV and TB epidemics..Comprised of 5 sections, the book details the following:..HIV epidemic inSouth Africa and the establishment of a research centre to undertakeclinical, epidemiological and laboratory research on HIV...CAPRISA’s clinical trials on HIV and HSV-2 prevention. These studiesinvestigated the impact of tenofovir gel as topical antiretroviralpre-exposure prophylaxis (PrEP), implementation of topical PrEP throughfamily planning clinics, conditional cash incentives for HIV prevention,HIV vaccines, and passive immunisation with broadly neutralising antibodies...CAPRISA’s r | | 出版日期 | Book 2017 | | 关键词 | AIDS; HIV; Clinical Trials; Prevention; Treatment; Tuberculosis; infectious diseases | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-319-47518-9 | | isbn_softcover | 978-3-319-83756-7 | | isbn_ebook | 978-3-319-47518-9 | | copyright | Springer International Publishing AG 2017 |
The information of publication is updating
|
|
|Archiver|手机版|小黑屋|
派博传思国际
( 京公网安备110108008328)
GMT+8, 2025-8-15 06:56
发表于 2025-3-21 18:12:25
